Potent induction therapy with interferon and ribavirin combination therapy does not achieve a higher sustained virological response rate in chronic hepatitis C with genotype 1b and high hepatitis C virus RNA level.

导出 LinkOut

翻译打印收藏纠错

第一作者： Shotaro,Enomoto

第一单位： Second Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan.

作者： Shotaro,Enomoto ^[1] ; Hideyuki,Tamai ; Masashi,Oka ; Naoki,Shingaki ; Tatsuya,Shiraki ; Machiko,Takeuchi ; Hisanobu,Deguchi ; Hirohito,Magari ; Izumi,Inoue ; Mikitaka,Iguchi ; Kimihiko,Yanaoka ; Kenji,Arii ; Mitsuhiro,Fujishiro ; Naohisa,Yahagi ; Hiroshi,Yotsuyanagi ; Masao,Ichinose

作者单位： Second Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan. ^[1]

DOI 10.1111/j.1872-034X.2007.00112.x

PMID 17573949

发布时间 2020-09-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览20

Hepatology research

2007年37卷9期

692-700页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Potent induction therapy with interferon and ribavirin combination therapy does not achieve a higher sustained virological response rate in chronic hepatitis C with genotype 1b and high hepatitis C virus RNA level.

Hepatology research

相似文献

Hepatology research

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Potent induction therapy with interferon and ribavirin combination therapy does not achieve a higher sustained virological response rate in chronic hepatitis C with genotype 1b and high hepatitis C virus RNA level.

Hepatology research

相似文献

Hepatology research

相关期刊

检索历史清除